Clinical Study to Evaluate the Efficacy and Safety of CKD-348(CKD-828, D326, D337) Tablet
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.
Also called NCT04388215
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 120 participants
- Registry
-
NCT04388215
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Unknown status
Technical summary
Registry record NCT04388215. Randomized; quadruple masking; primary purpose treatment. Start 2019-10-23 (actual); primary completion 2021-04 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Study to Evaluate the Efficacy and Safety of CKD-348(CKD-828, D326, D337) Tablet
- Condition
- Hypertension
- Condition
- Dyslipidemias
- Intervention (Drug)
- CKD-828
- Intervention (Drug)
- CKD-828(placebo)
- Intervention (Drug)
- D326
- Intervention (Drug)
- D326(placebo)
- Intervention (Drug)
- D337
- Intervention (Drug)
- D337(placebo)
- Intervention (Drug)
- D013
- Intervention (Drug)
- D013(placebo)
- Lead sponsor
- Chong Kun Dang Pharmaceutical
Record details
- Record id
cardio:ct-nct04388215- Content hash
bf10fc26bb97191526db6b2a0992aa6a1d910e1d3ff6a36e16f02c495bcb7912